My bookmarksSign up free

Commission Implementing Regulation (EU) 2019/716 ANNEX II

Commission Implementing Regulation (EU) 2019/716 ANNEX II

ANNEX IISupplementary provisions

ANNEX II The column ‘Specific provisions’ of row 31, cyflumetofen, in Part B of the Annex to Implementing Regulation (EU) No 540/2011 is replaced by the following: ‘Plant protection products containing cyflumetofen shall only be authorised for uses where the level of metabolite B3 in groundwater is expected to be below 0,1 μg/L. For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on cyflumetofen, and in particular Appendices I and II thereto, as finalised in the Standing Committee on the Food Chain and Animal Health on 20 November 2012 shall be taken into account. In this overall assessment, Member States shall pay particular attention to: — the protection of operators and workers; — the protection of groundwater, in particular for metabolite B3, when the substance is applied in regions with vulnerable soils and/or climatic conditions; — the protection of drinking water; — the risk to aquatic organisms. Conditions of use shall include risk mitigation measures, where appropriate.’

Read the full instrument →

Other provisions in Commission Implementing Regulation (EU) 2019/716

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX II of Commission Implementing Regulation (EU) 2019/716 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next